282 related articles for article (PubMed ID: 30232256)
21. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.
Mohamed E; Sierra RA; Trillo-Tinoco J; Cao Y; Innamarato P; Payne KK; de Mingo Pulido A; Mandula J; Zhang S; Thevenot P; Biswas S; Abdalla SK; Costich TL; Hänggi K; Anadon CM; Flores ER; Haura EB; Mehrotra S; Pilon-Thomas S; Ruffell B; Munn DH; Cubillos-Ruiz JR; Conejo-Garcia JR; Rodriguez PC
Immunity; 2020 Apr; 52(4):668-682.e7. PubMed ID: 32294407
[TBL] [Abstract][Full Text] [Related]
22. EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.
Huang S; Wang Z; Zhou J; Huang J; Zhou L; Luo J; Wan YY; Long H; Zhu B
Cancer Res; 2019 Apr; 79(8):2009-2020. PubMed ID: 30737232
[TBL] [Abstract][Full Text] [Related]
23. TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
Govers C; Sebestyén Z; Roszik J; van Brakel M; Berrevoets C; Szöőr Á; Panoutsopoulou K; Broertjes M; Van T; Vereb G; Szöllősi J; Debets R
J Immunol; 2014 Nov; 193(10):5315-26. PubMed ID: 25320284
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of Lck by Cbl ubiquitin ligase.
Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
[TBL] [Abstract][Full Text] [Related]
25. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells.
Sharma N; Akhade AS; Qadri A
Innate Immun; 2016 Apr; 22(3):238-44. PubMed ID: 26888964
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways.
Cochrane R; Clark RB; Huang CK; Cone RE
J Interferon Cytokine Res; 2001 Oct; 21(10):797-807. PubMed ID: 11710991
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
Zheng Y; Tian X; Wang T; Xia X; Cao F; Tian J; Xu P; Ma J; Xu H; Wang S
Mol Cancer; 2019 Mar; 18(1):61. PubMed ID: 30925926
[TBL] [Abstract][Full Text] [Related]
28. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
[TBL] [Abstract][Full Text] [Related]
29. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment.
Zhou J; Shen Q; Lin H; Hu L; Li G; Zhang X
J Cancer Res Clin Oncol; 2019 Feb; 145(2):329-336. PubMed ID: 30426212
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide:MHC molecules.
Lee JE; Cossoy MB; Chau LA; Singh B; Madrenas J
J Immunol; 1997 Jul; 159(1):61-9. PubMed ID: 9200439
[TBL] [Abstract][Full Text] [Related]
31. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses.
McNeill L; Salmond RJ; Cooper JC; Carret CK; Cassady-Cain RL; Roche-Molina M; Tandon P; Holmes N; Alexander DR
Immunity; 2007 Sep; 27(3):425-37. PubMed ID: 17719247
[TBL] [Abstract][Full Text] [Related]
32. Hirsutella sinensis Inhibits Lewis Lung Cancer via Tumor Microenvironment Effector T Cells in Mice.
Fu H; Jin L; Shao X; Li Y; Chen F; Shou Z; Tang X; Ji B; Shou Q
Am J Chin Med; 2018; 46(4):911-922. PubMed ID: 29754506
[TBL] [Abstract][Full Text] [Related]
33. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
[TBL] [Abstract][Full Text] [Related]
34. Requirement for p56(lck) tyrosine kinase activation in Th subset differentiation.
Yamashita M; Hashimoto K; Kimura M; Kubo M; Tada T; Nakayama T
Int Immunol; 1998 May; 10(5):577-91. PubMed ID: 9645606
[TBL] [Abstract][Full Text] [Related]
35. Co-ordination of the expression of the protein tyrosine kinase p56(lck) with the pre-T cell receptor during thymocyte development.
Buckland J; Pennington DJ; Bruno L; Owen MJ
Eur J Immunol; 2000 Jan; 30(1):8-18. PubMed ID: 10602022
[TBL] [Abstract][Full Text] [Related]
36. Superantigen-induced T cell:B cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70.
Morgan MM; Labno CM; Van Seventer GA; Denny MF; Straus DB; Burkhardt JK
J Immunol; 2001 Nov; 167(10):5708-18. PubMed ID: 11698443
[TBL] [Abstract][Full Text] [Related]
37. Superantigen stimulation reveals the contribution of Lck to negative regulation of T cell activation.
Criado G; Madrenas J
J Immunol; 2004 Jan; 172(1):222-30. PubMed ID: 14688329
[TBL] [Abstract][Full Text] [Related]
38. Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.
Gibson S; Truitt K; Lu Y; Lapushin R; Khan H; Imboden JB; Mills GB
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1123-8. PubMed ID: 9494076
[TBL] [Abstract][Full Text] [Related]
39. The pool of preactivated Lck in the initiation of T-cell signaling: a critical re-evaluation of the Lck standby model.
Ballek O; Valečka J; Manning J; Filipp D
Immunol Cell Biol; 2015 Apr; 93(4):384-95. PubMed ID: 25420722
[TBL] [Abstract][Full Text] [Related]
40. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]